Clinical Report: Assessment of Delays in Diagnosis of Coeliac Disease in Turkey
Overview
This study investigates the median diagnostic delay of celiac disease (CD) in pediatric patients across Turkey, revealing a median delay of 7.3 months. The findings highlight the need for improved diagnostic strategies to reduce delays and associated complications.
Background
Celiac disease is a prevalent autoimmune disorder that can lead to significant health complications if not diagnosed early. The variability in clinical presentation often results in diagnostic delays, which can exacerbate conditions like malnutrition and osteoporosis. Understanding the factors contributing to these delays is crucial for improving patient outcomes.
Data Highlights
Region
Percentage of Patients
Southeastern Anatolia
33.0%
Eastern Anatolia
18.6%
Mediterranean
18.1%
Marmara
17.0%
Aegean
8.5%
Black Sea
4.8%
Key Findings
The median age of participants diagnosed with CD was 8.49 years.
The median delay from symptom onset to diagnosis was 7.30 months.
8.5% of patients were diagnosed more than three years after the onset of symptoms.
There were no significant differences in diagnostic delays between different regions of Turkey.
Screening of high-risk, asymptomatic children was associated with shorter diagnostic delays.
Clinical Implications
Healthcare providers should be aware of the potential for significant diagnostic delays in pediatric celiac disease. Implementing targeted screening strategies for high-risk groups may facilitate earlier diagnosis and intervention, thereby reducing the risk of long-term complications.
Conclusion
The findings underscore the importance of timely diagnosis of celiac disease in children to prevent adverse health outcomes. Enhanced awareness and targeted screening could significantly improve diagnostic timelines.
